B. Braun’s Supplier Recall of Heparin API Prompts Voluntary Recall of Heparin Solutions
Scientific Protein Laboratories LLC (SPL) manufactures Heparin Sodium USP active pharmaceutical ingredient that is used by B. Braun Medical Inc. to produce Heparin Sodium in 5% Dextrose and 0.9% Sodium Chloride injection solution
Irvine, CA — March 21, 2008 — B. Braun Medical Inc. was recently notified by its supplier, Scientific Protein Laboratories LLC (SPL) of a nationwide recall of Heparin Sodium USP active pharmaceutical ingredient (API). The voluntary recall affects the following 23 Finished Product (FP) lots manufactured and distributed by B. Braun Medical Inc. nationwide and to Canada.
B. Braun FP Lot # |
B. Braun FP Material |
Description |
NDC Numbers |
CAN DIN |
J7D490 |
P5872 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
0264-9587-20 |
N/A |
J7C684 |
P5771 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
0264-9577-10 |
N/A |
J7D496 |
P5771 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
0264-9577-10 |
N/A |
J7C470 |
P5872 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
0264-9587-20 |
N/A |
J7D580 |
P5671-00 |
Heparin Sodium 20,000 Units in 5% Dextrose Injection (500mL) |
N/A |
02209713 |
J7E420 |
P5872-00 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
N/A |
02209721 |
J7C611 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7C557 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7C477 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7C705 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7D485 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7E415 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7E416 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7E494 |
P5872 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
0264-9587-20 |
N/A |
J7E500 |
P5771 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
0264-9577-10 |
N/A |
J7E577 |
P5771-00 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
N/A |
01935941 |
J7E489 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7N556 |
P5872 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
0264-9587-20 |
N/A |
J7P404 |
P5771 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
0264-9577-10 |
N/A |
J7N604 |
P5771 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (500mL) |
0264-9577-10 |
N/A |
J7P476 |
P5872 |
Heparin Sodium 25,000 Units in 5% Dextrose Injection (250mL) |
0264-9587-20 |
N/A |
J7N519 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
J7N676 |
P8721 |
Heparin Sodium 1000 Units in 0.9% Sodium Chloride Injection (500mL) |
0264-9872-10 |
01935933 |
B. Braun Medical Inc. began recalling the lots on March 21, 2008 as a precautionary measure. This product recall was initiated due to a notification received from the supplier, Scientific Protein Laboratories (SPL), disclosing that one lot of Heparin Sodium, USP Active Pharmaceutical Ingredient acquired by B. Braun Medical Inc. has a heparin-like contaminant. To date, B. Braun Medical Inc. has not received any adverse event reports related to this issue.
The Food and Drug Administration has received reports of serious injuries and/or deaths in patients who have been administered Heparin injectable products of other companies containing this contaminant. As indicated in the notification issued by the supplier SPL, typical symptoms include anaphylactic-like reactions such as low blood pressure, shortness of breath, nausea, vomiting, diarrhea and abdominal pain.
Have you received this defective medical product?
Customers who have this defective medical product in their possession from the recalled product lots should discontinue use immediately. Patients reporting any problems that may be related to the use of this product should contact a physician.
If you or a loved one has been injured by this defective medical product, you may be entitled to compensation. A defective medical products lawyer can explain your options for holding those who are responsible accountable.
Contact a Defective Medical Products Attorney
If you have questions, contact a medical injury lawyer online or by calling toll-free 1-866-222-2606. Initial consultation is FREE.